Prevalence of hepatitis C in the general population in the Netherlands

Netherlands Journal of Medicine

Volumn 66, Issue 1, 2008, Pages 13-17

  Slavenburg, S ^a   Verduyn Lunel, F M ^a   Hermsen, J T ^b   Melchers, W J G ^a   Te Morsche, R H M ^a   Drenth, J P H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Diagnostic Medical Centre   (Netherlands)

Author keywords

Hepatitis C; Prevalence; The Netherlands

Indexed keywords

EDETIC ACID; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; NETHERLANDS; POPULATION RESEARCH; PREVALENCE; RANDOM SAMPLE; SCREENING; SEROLOGY; SEX RATIO; URBAN AREA;

CHRONIC DISEASE; EPIDEMIOLOGIC STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NETHERLANDS; PREVALENCE; PROSPECTIVE STUDIES;

EID: 38849199656     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003;362:2095-100.
2. Mendez-Sanchez N, Ponciano-Rodriguez G, et al. Prevalence of hepatitis C infection in a population of asymptornatic people in a checkup unit in Mexico city. Dig Dis SCi 2005;50:733-7.
3. WHO. Hepatitis C. Accessed at http://www.who.int/mediacentre/factsheets/ fs164/en/ on 21 February 2005.
4. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
5. Yen T, Keeffe EB, Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol 2003;36:47-53.
6. Cole A. Hepatitis C morbidity is set to double in next decade. BMJ 2007;334:10.
7. Health Protection Agency. Hepatitis C in England: The Health Protection Agency Annual Report 2006. Accessed at http://www.hpa.org.uk/ publications/2006/hepc_2006/Hepatitis_C2.pdf on 1 December 2006.
8. Van den Hoek JA, van Haastrecht HJ, Goudsmit J, de Wolf F, Coutinho RA. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 1990;162:823-6.
9. Schneeberger PM, Keur I, van Loon AM, et al. The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: a nationwide prospective study. J Infect Dis 2000;182:1291-9.
10. Op de Coul E, Bosman A, van de Laar M. Surveillance van hepatitis C in Nederland, 1992-2002. Inf Bull 2003;14:323-8.
11. Health Council of the Netherlands: Committee on hepatitis C. Detection and treatment of people with hepatitis C. 1997.
12. Stuyver L, Wyseur A, van Arnhem W, Hernandez F, Maertens G. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 1996;34:2259-66.
13. Stichting Sanquin Bloedvoorziening. Sanquin jaarverslag 2000. Amsterdam, 2001 http://rivm.openrepository.com/rivm/bitstream/100 29/9230/1/ 605148010.pdf.2001.
14. Booth JC, O'Grady J, Neuberger J. Clinical guidelines on the management ofhepatitis C. Gut 2001 Jul;49 Suppl 1:11-21.
15. Veldhuijzen IK, Conyn-van Spaendonck MAE, Dorigo-Zwetsma JW. Seroprevalentie van hepatitis B en C in de Nederlandse bevolking. Inf Bull 1999;10:182-4.
16. De Melker HE, Conyn-van Spaendonck MAE. Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiol Infect 1998;121:637-43.
17. van der Weijden T, van Bokhoven MA, Dinant GJ, van Hasselt CM, Grol RP. Understanding laboratory testing in diagnostic uncertainty: a qualitative study in general practice. Br J Gen Pract 2002;52:974-80.
18. Verstappen WH, ter Riet G, Dubois WI, Winkens R, Grol RP, van der Weijden T. Variation in test ordering behaviour of GPs: professional or context-related factors? Fam Pract 2004;21:387-95.
19. Van Wijk MA, van der Lei J, Mosseveld M, Bohnen AM, van Bemmel JH. Compliance of general practitioners with a guideline-based decision support system for ordering blood tests. Clin Chem 2002;48:55-60.
20. Statistics Netherlands (CBS), CBS table: Population per region subdivided to country and gender, 1 January 2006 http://statline.cbs.nl/ StatWeb/table.asp?STB=G1&LA=nl&DM=SLNL&PA=37713&D1 =0&D2=a&D3=0,26,35,403,485, 680-691&D4=0&D5=1&HDR=G4,T,G3,G2. 2006.
21. CDC. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR 2003;52 (No. RR-3):1-16 http://www.cdc.gov/ mmwr/preview/mmwrhtml/rr5203a1.htm. 2003.
22. De Vries MJ, te Rijdt B, van Nieuwkerk CM. Genotype distribution amongst hepatitis C patients in the Netherlands. Neth J Med 2006;64:109-13.
23. Palitzsch KD, Hottentrager B, Schlottmann K, et al. Prevalence of antibodies against hepatitis C virus in the adult German population. Eur J Gastroenterol Hepatol 1999;11:1215-20.
24. Dubois F, Desenclos JC, Mariotte N, Goudeau A. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group. Hepatology 1997;25:1490-6.
25. Beutels M, Van Damme P, Aelvoet W, et al. Prevalence of hepatitis A, B and C in the Flemish population. Eur J Epidemiool 1997;13:275-80.
26. Raffaele A, Valenti M, Iovenitti M, et al. High prevalence of HCV infection among the general population in a rural area of central Italy. Eur J Epidemiol 2001;17:41-6.
27. Riestra S, Fernandez E, Leiva P, Garcia S, Ocio G, Rodrigo L. Prevalence of hepatitis C virus infection in the general population of northern Spain. Eur J Gastroenterol Hepatol 2001;13:477-81.
28. Di Stefano SR, Stroffolini T, Ferraro D, Usticano A, Valenza LM, Montalbano L, et al. Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission. J Med Virol 2002;67:339-44.